NFKB1 and diabetic kidney disease: However, one study showed that lncRNA MIAT blocked the high glucose-mediated cell damage and activation of NF-κB via sponging miR-182-5p and elevating the GPRC5A expression in diabetic nephropathy, leading to suppression of diabetic nephropathy progression (51).